首页> 美国卫生研究院文献>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease >Multiple Risk Factor Intervention Trial Revisited: A New Perspective Based on Nonfatal and Fatal Composite Endpoints Coronary and Cardiovascular During the Trial
【2h】

Multiple Risk Factor Intervention Trial Revisited: A New Perspective Based on Nonfatal and Fatal Composite Endpoints Coronary and Cardiovascular During the Trial

机译:再次探讨多重危险因素干预试验:基于非致命和致命复合终点冠心病和心血管疾病的新观点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe Multiple Risk Factor Intervention Trial evaluated a multifactor intervention on coronary heart disease (CHD) in 12 866 men. A priori defined endpoints (CHD death, CHD death or nonfatal myocardial infarction, cardiovascular disease [CVD] death, and all-cause death) did not differ significantly between the special intervention (SI) and usual care (UC) groups over an average follow-up period of 7 years. Event rates were lower than anticipated, reducing power. Other nonfatal CVD outcomes were prespecified but not considered in composite outcomes comparing SI with UC.
机译:背景多危险因素干预试验评估了对12 866名男性的冠心病(CHD)的多因素干预。在平均随访期间,特殊干预(SI)组和常规护理(UC)组之间的先验定义终点(CHD死亡,CHD死亡或非致命性心肌梗塞,心血管疾病[CVD]死亡和全因死亡)没有显着差异。长达7年。事件发生率低于预期,从而降低了功耗。预先规定了其他非致命性CVD结果,但在比较SI与UC的综合结果中未考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号